MSN Home  |  My MSN  |  Hotmail
Sign in to Windows Live ID Web Search:   
go to MSNGroups 
Free Forum Hosting
 
Important Announcement Important Announcement
The MSN Groups service will close in February 2009. You can move your group to Multiply, MSN’s partner for online groups. Learn More
The Peaceful OasisContains "mature" content, but not necessarily adult.[email protected] 
  
What's New
  
  Happy New Year!!  
  Merry Christmas!!  
  Starting/Welcome Page  
  Christmas Music  
  Christmas and Holiday Threads  
  member profiles  
  Message Archives  
  Search This Site  
  OASIS RADIO ROOM  
  Music Lyrics  
  POEM OF THE WEEK!  
  YOUR VOTE COUNTS!  
  Rate This Community!  
  Name Signatures  
  GAME PAGE  
  Creative Spirits  
  Message Board  
  Links  
  IN MEMORY OF....  
  Pictures  
  LINKS!!!!!  
  Banner Exchange  
    
    
  USEFUL ARTICLES  
  Happy Birthday!  
  Depression Info  
  Medical Info  
  Ecards Etc..  
  Holiday Page  
  Managers Page  
  backrounds 1  
  my critters  
  religious backrounds  
  music  
  Search This Site  
  test  
  backrounds 2  
  my backrounds  
  In Memory Of Tiger  
  In Memory Of Oreo  
  Animal Backgrounds  
  In Memory Of Teddy  
  
  
  Tools  
 
General : Depression
Choose another message board
 
     
Reply
 Message 1 of 1 in Discussion 
From: 2many  (Original Message)Sent: 9/2/2003 5:34 AM
Survey: Manic Depressives Not Getting New Drugs
By Patricia Reaney

LONDON (Reuters) - More than half the manic depressives in Britain are not receiving available new drugs that have fewer side effects, medical experts said on Friday.

Bipolar disorder, or manic depression, affects about one in every 100 people in Britain. Older drugs control the mood swings but also produce serious side effects such as muscle stiffness, tremors and agitation. They are, however, cheaper.

"There are still some old medications that have a place, such as lithium. However with antipsychotics, which are used very widely in bipolar disorder, the new ones are usually preferred because they have a great tolerability," said Professor Allan Young, of Newscastle's Royal Victoria Hospital.

"The barriers to using the new drugs tend to be costs and perhaps a lack of evidence for their use in bipolar disorder. Certainly the cost is a critical issue," he added.

In a survey of 841 people with bipolar disorder, only 12 percent of patients were taking the newer treatments. Ninety percent of people on older, typical antipsychotics described the drugs as "the worst they had ever taken."

A quarter of people questioned in the survey also had sexual side effects, including impotence and low sperm production. More than 40 percent stopped taking the medication because of the unwanted side effects.

About one in five people who have stopped treatment eventually commit suicide, according to the Manic Depression Fellowship (MDF) charity.

"The data show that patients are still receiving cheaper, older drugs, which can cause distressing and debilitating side effects, despite the fact that there are more effective and better tolerated treatments available," said Michelle Rowett, chief executive of MDF, which conducted the survey.

Britain's National Institute of Clinical Excellence, a cost-effectiveness watchdog, is conducting a review of newer treatments for bipolar disorder.

"We need to have an agreement that the use of new treatments will be funded by healthcare systems," Young added.

Last Updated: 2003-05-16 10:00:32 -0400 (Reuters Health)



First  Previous  No Replies  Next  Last